News

As per the previous agreement, UniPharma had the exclusive right to distribute Radient’s cancer test in Taiwan. The expanded distribution agreement includes Singapore, Hong Kong and Macau. As

Under the terms of the collaboration, Anika will receive an initial payment of $2.5m besides being entitled to receive additional payments from after the launch of the product

Gevokizumab, a humanized monoclonal antibody, acts by suppressing the activation of interleukin-1 beta (IL-1 beta), a pro-inflammatory cytokine, thereby modulating the cellular signaling events that produce inflammation. The

The initiative is believed to enable Novocol to diversify and develop new infection control products thereby increasing its competitiveness globally. Novocol is investing over $54m in the project

The milestone payment was made under the terms of the agreement between Purdue and Transcept for the commercialization of Intermezzo in the US. Intermezzo (zolpidem tartrate) sublingual tablet

BioSystem Development’s AssayMAP platform, based on disposable microchromatography cartridges, enables for the first time, automation of complex, multi-step sample preparation workflows. They include protein purification, characterization and analysis

JX-594 is a proprietary, engineered oncolytic virus that will selectively target and destroy cancer cells by degrading cancer cells through viral replication, blocking the blood supply to tumors

According to the company, Scenesse is the first photoprotective drug developed as a prophylactic treatment for phototoxicity experienced by patients with EPP, a rare light intolerance disease. CUV029,

The new clinical distribution network to serve the pharmaceutical community has been built on Marken’s current Latin America business which serves more than 1200 clinical research investigator sites